API
MDT icon

Advisor Partners II’s Medtronic MDT Stock Holding History

Advisor Partners II’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.04M Sell
38,855
-642
-2% -$53.7K 0.12% 174
2023
Q2 		$3.48M Buy
39,497
+6,566
+20% +$565K 0.16% 121
2023
Q1 		$2.65M Buy
32,931
+4,820
+17% +$393K 0.15% 136
2022
Q4 		$2.18M Sell
28,111
-5,975
-18% -$484K 0.14% 159
2022
Q3 		$2.75M Buy
+34,086
New +$3.06M 0.21% 100

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advisor Partners II's MDT Position: Q3 2023 in Review

Advisor Partners II reduced its Medtronic (MDT) stake by 1.6% in Q3 2023, selling an estimated $53.7K and leaving 38,855 shares worth $3.04M. The position accounts for 0.12% of the portfolio, ranked #174.

Advisor Partners II first reported a position in MDT in Q3 2022 and has held it in 5 quarters since. The position peaked at $3.48M in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Advisor Partners II held 38,855 shares of Medtronic worth $3.04M as of Q3 2023.
  • Advisor Partners II sold 642 Medtronic shares in Q3 2023, an estimated $53.7K.
  • Medtronic made up 0.12% of Advisor Partners II's portfolio in Q3 2023, its #174 holding.
  • Advisor Partners II first reported a position in Medtronic in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Medtronic position peaked at $3.48M in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.